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Abstract Helicobacter pylori upregulates endothelial adhesion
molecules but the pattern is unclear. Human umbilical vein en-
dothelial cells (HUVEC) were exposed to control medium or
H. pylori 60190. Binding of monoclonal antibodies against
P-selectin, E-selectin, vascular adhesion molecule-1 (VCAM-1)
and intercellular adhesion molecule-1 (ICAM-1) was determined
using enzyme-linked immunosorbent assay. Binding of polymor-
phonuclear leukocytes to HUVEC was determined on cells ex-
posed as above. After 6 h exposure to H. pylori, there were
30%, 124%, 167% and 100% increases in P-selectin, E-selectin,
VCAM-1 and ICAM-1 levels and a 400% increase in polymor-
phonuclear leukocyte adhesion in HUVEC exposed to H. pylori.
E¡ects of incubation for other intervals between 0 and 18 h are
also described. H. pylori exerts some of its e¡ects on gastric
mucosa via gastric vasculature. This study gives insight into the
pattern of H. pylori-associated endothelial adhesion molecule
upregulation.
4 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The urease-producing microorganism Helicobacter pylori
plays a critical role in peptic ulcer disease, with up to 95%
of duodenal ulcers and 80% of gastric ulcers associated with
H. pylori infection [1]. H. pylori is also implicated in the de-
velopment of certain gastric cancers, namely gastric adenocar-
cinoma and mucosa-associated lymphoid tissue lymphoma [2].
The exact pathogenic mechanisms by which H. pylori exerts
its e¡ects on the stomach are still not entirely understood but
there are certainly several factors to take into account. There
is growing evidence that H. pylori exerts some of its e¡ects on
the stomach by actions on the gastric vasculature. Leukocyte^
endothelial cell interactions play critical roles in in£ammatory
conditions of the gastrointestinal tract [3]. We have previously
demonstrated upregulation of both cyclooxygenase-1 and -2
by H. pylori in an endothelial cell model [4]. H. pylori is a
non-invasive organism and resides in the mucus layer over-
lying the gastric mucosa but it is felt that shed or secreted
products may transmigrate and act, indirectly through other
messengers or directly, to stimulate neutrophil activity and
migration into the gastric mucosa [5^8]. During in£ammation,
recruitment of leukocytes to the endothelium is followed by
migration to the gastric epithelial layer. This is a key factor
involved in the gastroduodenal in£ammation caused by
H. pylori [9]. In vitro studies have shown that H. pylori ex-
tracts are chemotactic for monocytes and neutrophils [7,8]. In
order for activated leukocytes to reach the gastric mucosa,
they ¢rst need to adhere to the vascular endothelium
[10,11]. Leukocyte adherence and emigration from the vascu-
lature have been shown in mesenteric venules super-perfused
with H. pylori [12]. There was also increased albumin leakage
from vessels and platelet^leukocyte aggregation [12,13]. More
recently, it has been shown that water extracts of H. pylori
induce expression of CD11b/CD18 on granulocytes. However,
it is still not entirely clear to which adhesion molecules on
endothelial cells the activated neutrophils bind as the pattern
of upregulation varies between studies [14,15].
There are several families of adhesion molecules that are
expressed on the endothelial cell surface either constitutively
or following endothelial cell activation. Selectins are a family
of adhesive receptors on endothelial cells, platelets and leuko-
cytes [16,17]. P-selectin is located either in the K-granules of
platelets or in the Weibel^Palade bodies of endothelial cells
and is translocated to the cell surface upon activation by in-
£ammatory stimuli such as thrombin or histamine. L-selectin
is also expressed on the surface of leukocytes following similar
activation and E-selectin is expressed on endothelial cells fol-
lowing exposure to in£ammatory cytokines. Vascular adhe-
sion molecule-1 (VCAM-1) and intercellular adhesion mole-
cule-1 (ICAM-1) are members of the immunoglobulin
superfamily that are expressed following endothelial cell ex-
posure to cytokines for several hours [18,19].
The aim of this study was to examine the early e¡ects of
H. pylori on the expression of vascular endothelial adhesion
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molecules and to measure the subsequent leukocyte^endothe-
lial interactions.
2. Materials and methods
All laboratory reagents were from Sigma Chemical Company (St.
Louis, MO, USA) unless otherwise stated. Culture medium (M199),
foetal bovine serum (FBS), antibiotics, Hanks’ balanced salt solution
(HBSS), phosphate-bu¡ered saline (PBS) and HEPES were from Life
Technologies (Paisley, UK).
2.1. Culture of human umbilical vein endothelial cells (HUVEC)
HUVEC were isolated and grown in culture as described by Ja¡e et
al. [20]. Brie£y, cells were isolated from human umbilical vein cords
by enzymatic digestion using collagenase type II (Worthington Chem-
ical Company, Freehold, NJ, USA) and grown in M199 supplemented
with 20% FBS and penicillin/streptomycin (100 units). Endothelial
cell mitogen (Biogenesis, Poole, UK) was solubilised with heparin
(1000 U) and added at a ¢nal concentration of 100 Wg/ml. Cells were
grown to con£uence on 0.2% gelatin-coated 75-cm2 £asks (Costar,
Cambridge, MA, USA) in a humidi¢ed atmosphere at 37‡C in 5%
CO2. Con£uent primary cultures were routinely passaged by trypsin/
EDTA or EDTA digestion and expanded through passages 2^3. Eth-
ical approval for use of umbilical cords collected from Holles Street
Maternity Hospital for isolation of HUVEC was given by the Royal
College of Surgeons in Ireland ethics committee.
2.2. Enzyme-linked immunosorbent assays
Binding of monoclonal antibodies to HUVEC, that were either
resting or stimulated with interleukin (IL) 1L or H. pylori 60190,
was carried out according to the method of Murphy et al. [21]. Brie£y,
HUVEC were grown to con£uence on 96-well microtitre plates and
stimulated with IL-1L (100 U/ml) or H. pylori for 3, 6, 12 and 18 h.
Wells were then emptied and washed three times with RPMI/2.5%
FBS containing sodium azide (0.1%). HUVEC were then incubated
with monoclonal antibodies directed against P-selectin, E-selectin,
ICAM-1 and VCAM-1 (RpD Systems, Minneapolis, MN, USA) in
RPMI/2.5% FBS for 1 h, washed again three times and added with a
goat anti-mouse IgG/horseradish peroxidase conjugate in PBS. ABTS
was used to detect bound monoclonal antibody.
2.3. Polymorphonuclear leukocyte (PMN) isolation
Routine isolation of PMN was performed under sterile conditions
using Ficoll-Hypaque endotoxin-free Histopaque in a gradient density
centrifugation technique followed by erythrocyte lysis [22]. Whole
blood was drawn from donors on acid/citrate/dextrose, carefully lay-
ered on gradient and centrifuged at 2500 rpm for 25 min at room
temperature. Lysing bu¡er (0.154 M ammonium chloride, 19 mM
potassium bicarbonate, 1 mM EDTA) was added to the pellet con-
taining erythrocytes and PMN for 10 min, centrifuged at 1500 rpm for
5 min and the PMN pellet washed three times with PBS. Cells were
washed twice in PBS in RPMI for adhesion studies.
2.4. PMN^HUVEC adhesion assays
HUVEC were grown to con£uence on 24-well plates and then
added with M199/2.5% FBS in the presence or absence of IL-1L
(100 U/ml) or H. pylori for 6 h. Isolated PMN were suspended in
RPMI media at 0.5^1U106 cells/ml then added to each of the 24-well
plates and incubated for 20^30 min at 37‡C. Wells were then washed
carefully three times to remove unbound PMN and bound cells lysed
and assayed for myeloperoxidase (MPO) activity [23,24]. Lysed cells
were added with HBSS (0.3 ml), phosphate bu¡er (pH 6.4, 0.2 ml),
dimethoxybenzidine (O-dianisidine HCl (50 Wl) and H2O2 (50 Wl). The
colour product was measured spectrophotometrically (Titertek, Multi-
scan) at 450 nm. Standard curves were plotted for each assay using
PMN ranging between 0.03U105 and 2U105 cells/ml and the number
of adherent cells determined from this. There is no MPO in HUVEC
[24].
2.5. Statistics
Data were analysed using analysis of variance (ANOVA) followed
by Dunnett multiple comparisons test if the ANOVA showed signi¢-
cant di¡erence when comparing all columns. The data are expressed
as meanPS.E.M.
3. Results
3.1. H. pylori induces endothelial cell adhesion molecule
expression (Fig. 1)
HUVEC were exposed to H. pylori 60190 over a time
course of 3, 6, 12 and 18 h. The maximum increase in
P-selectin, E-selectin, and VCAM-1 after stimulation with
H. pylori or IL-1L occurred at 3^6 h, other than for ICAM-
1 where the maximum induction occurred at 12 h. Fig. 1
shows the results of the 6-h incubations. Repeated measures
ANOVA comparing the e¡ects of IL-1L and H. pylori after 6 h
on adhesion molecule expression compared to unstimulated
cells was performed for P-selectin (P6 0.0001), E-selectin
(P6 0.0001), VCAM (P=0.0004) and ICAM (P6 0.0001).
There were 30% (P 1.4%), 124% (P 5%), 167% (P 14%) and
100% (P 7%) increases in the absorbance readings for P-selec-
tin, E-selectin, VCAM-1 and ICAM-1 respectively in HUVEC
exposed to H. pylori for 6 h relative to controls (Fig. 1).
Dunnett multiple comparisons tests were performed for each
of the adhesion molecules, and the e¡ects of IL-1L (n=4,
P6 0.01 v. control) and H. pylori (n=4, P6 0.01 v. control)
were signi¢cant for each of the adhesion molecules. Fig. 2
summarises the patterns over the various time courses.
3.2. H. pylori-induced endothelial cell adhesion molecule
expression mediates neutrophil adhesion (Fig. 3)
PMN were isolated from freshly drawn blood as described
in Section 2 and layered onto HUVEC for 30 min. ANOVA
comparing the e¡ects of IL-1L and H. pylori on PMN adhe-
sion against control cells was signi¢cant at P=0.0018. Dun-
nett multiple comparisons test showed that IL-1L signi¢cantly
increased the adhesion of PMN to HUVEC (n=3, P6 0.05 v.
control). The di¡erence between control cells and those ex-
Fig. 1. H. pylori induces adhesion molecule expression in endothelial
cells. HUVEC were seeded on 96-well tissue culture plates, grown
to con£uence and treated with IL-1L (100 U/ml) or H. pylori for
6 h. Antibodies directed against P-selectin, E-selectin, VCAM-1 and
ICAM-1 (5 Wg/ml) were then added and binding measured as de-
scribed in Section 2. Binding was increased to varying degrees on
all treated cells compared to resting cells. Data represent duplicate
determinations from four independent experiments. *P6 0.01
against control for each of P-selectin, E-selectin, VCAM and
ICAM.
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posed to H. pylori was even more signi¢cant (n=3, P6 0.01 v.
control). There was a 250P 9% increase in PMN adhesion to
IL-1L-treated HUVEC and an even more pronounced
400P 12% increase on the H. pylori-treated cells. The en-
hanced expression on the H. pylori-treated cells correlates
well with the increase in adhesion molecule expression as
seen in Fig. 1.
4. Discussion
Early studies using immunohistochemistry showed that
lymphocyte in¢ltration in the gastric epithelium is important
in the in£ammatory response to H. pylori infection. There are
several sources of evidence suggesting that some of the dele-
terious e¡ects of H. pylori may be mediated through actions
on the gastric microvasculature [3,12,25^27]. Several groups
have shown that H. pylori promotes leukocyte adhesion to
endothelial cells and a chemotactic response resulting in em-
igration of neutrophils and accumulation in the interstitium
[7,8,13].
It is clear that endothelial adhesion molecules play a critical
role in the neutrophil in¢ltration in H. pylori-associated in-
£ammation [12,14]. We chose an in vitro model using HU-
VEC to determine the e¡ects of H. pylori on the expression of
endothelial P-selectin, E-selectin, VCAM-1 and ICAM-1. Pre-
vious work in this ¢eld has shown upregulation of a variety of
adhesion molecules in endothelial cells but the pattern of up-
regulation varies signi¢cantly between studies [12,14]. It has
also been suggested that the pattern of adhesion molecule
expression varies between di¡erent in£ammatory settings,
for example H. pylori-associated gastritis and in£ammatory
bowel disease [15]. In this study, we found that H. pylori
caused upregulation of endothelial E-selectin and P-selectin
as well as VCAM-1 and ICAM-1.
In H. pylori models, some studies have highlighted the roles
of VCAM-1 and ICAM-1 in neutrophil adhesion to endothe-
lium [15,28]. ICAM-1 is known to be important in leukocyte
adherence and emigration and is constitutively expressed on
endothelial cells [18]. Activation of endothelial cells with lipo-
polysaccharide (LPS) causes upregulation of ICAM-1 expres-
sion [29,30]. Indeed, maximum levels of leukocyte adherence
are associated with ICAM-1 expression [31]. The importance
of induction of the constitutively expressed ICAM-1 molecule
by H. pylori was con¢rmed in our study in keeping with
previous work. VCAM-1 is also involved in adherence of leu-
kocytes but is not present on resting HUVEC. However, bac-
terial LPS can elicit upregulation [32]. In our work, there was
little baseline expression of VCAM-1 but marked upregula-
tion with IL-1L and even greater induction with H. pylori.
Our ¢ndings in relation to the involvement of the selectin
family of adhesion molecules are interesting. We found upreg-
ulation of both P- and E-selectin with H. pylori. Hatz et al.
[15] suggest using immunohistochemical studies that H. pylori
does not lead to upregulation of P-selectin. They did however
comment that an enhanced steady state of P-selectin expres-
sion in H. pylori-associated gastritis may be missed by immu-
nohistochemical methods. P-selectin is normally found in the
K granules of platelets and Weibel^Palade bodies of endothe-
lial cells [33]. These granules are translocated to the cell sur-
face and expressed brie£y upon activation with agents such as
thrombin or histamine, before returning to basal levels within
minutes [34]. Previous work has shown that, in addition to
mobilisation of the preformed pool, bacterial endotoxin exerts
transcriptional regulation upon P-selectin expression and is
responsible for the more prolonged elevation of P-selectin
[35]. Upregulation of P-selectin is also known to be important
in H. pylori activation of platelets [36].
Unlike P-selectin, there is no E-selectin present normally on
the surface of resting endothelial cells and neither is there a
preformed pool [16]. Darveau et al. [37] showed in an in vitro
study that intact H. pylori cell wall preparations or LPS of
H. pylori did not upregulate E-selectin in a HUVEC model.
However, they found that other bacteria such as Escherichia
Fig. 2. Time course of e¡ects of H. pylori (a) and IL-1L (b) on ad-
hesion molecules.
Fig. 3. H. pylori-induced endothelial cell adhesion molecule expres-
sion mediates neutrophil adhesion. HUVEC were seeded on 24-well
tissue culture plates, grown to con£uence and treated with IL-1L
(100 U/ml) or H. pylori for 6 h. PMN were isolated and added to
cells for 30 min, unbound cells washed o¡ and the number of ad-
hered cells quanti¢ed by measurement of MPO activity as described
in Section 2. Data represent triplicate determinations from three in-
dependent experiments. *P6 0.05, **P6 0.01 against control.
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coli did upregulate E-selectin. The suggestion was that lower
gut bacteria such as E. coli may in part be responsible for the
E-selectin expression seen in in£ammatory conditions of the
lower gastro-intestinal tract such as Crohn’s disease. Several
studies have shown that E-selectin is the ¢rst adhesion mole-
cule upregulated in response to LPS or IL-1 but that its ex-
pression peaks at around 3 h and is near baseline levels by 8 h
[38]. One conclusion from these studies was that E-selectin
does not appear to be involved in continued leukocyte adher-
ence to endothelium and rolling after the initiation of the
in£ammatory process and that it has no or little involvement
in the in£ammation associated with H. pylori. We found after
exposure of endothelial cells to H. pylori for a 6-h period that
there was an increase in E-selectin expression was signi¢cantly
greater than that for P-selectin. Although we did not assess
leukocyte rolling, we hypothesise that E-selectin may be in-
volved in the continued rolling of leukocytes in H. pylori-
associated in£ammation and that E-selectin may be more im-
portant in this process than originally thought.
Although we did not con¢rm that the ¢ve-fold increase we
observed in neutrophil adhesion to activated endothelial cells
is dependent on adhesion molecule expression, previous stud-
ies have shown this to be the mechanism [12,14]. Neutrophil
in¢ltration into the submucosa is a prominent feature of
H. pylori-associated in£ammation in the stomach.
In this study, we show that as well as VCAM-1 and ICAM-
1, E-selectin and P-selectin also play important roles and that
E-selectin may be more involved in the ongoing in£ammatory
process than originally thought. This pattern of adhesion mol-
ecule induction allows adherence to endothelium and subse-
quent transmigration of neutrophils. This supports the idea
that H. pylori exerts some of its e¡ects on the gastric mucosa
through e¡ects on the gastric vasculature as well as the direct
injurious e¡ects on the gastric mucosa previously described.
Understanding the pattern of adhesion molecule expression in
H. pylori-associated disease will allow further insight into the
pathogenesis of H. pylori-associated in£ammation and its pro-
gression to ulcer disease or gastric cancer.
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